Research News

How does the HTA work?

Friday, 27 February 2015 16:20

The first of a series of articles from Professor Tom Walley, Director of the NIHR HTA Programme, covers how the HTA staff prioritise topics for research and for funding.

NIHR CRN Senior Clinical Leadership role

Friday, 20 February 2015 14:01

Steve Ryder has announced that he will be stepping down from his long-held position as chair of the NIHR CRN Hepatology Group. Writing to the Local Leads, he said "I have chaired the CRN: Hepatology SIG from its inception and while I can honestly say it has been one of the most rewarding and positive experiences of my career I feel that it is time for someone new to take things forward. Thank you all for your support and work which has made Hepatology such a success within the NIHR CRN."

Information and the application for the Specialty National Lead post can be found via the link on the University of Leeds website: The advert is also on the BMJ website . The application deadline is 16 March.

There is also a further advert for NIHR CRN Theme Lead, closing date 28/02/15:

If you need more information on either of these roles please contact This e-mail address is being protected from spambots. You need JavaScript enabled to view it .  

Chief Investigator/Study Team of the Year award - NIHR Portfolio research in the North East and North Cumbria

Thursday, 05 February 2015 15:03

Professor Colin Rees and the DISCARD2 Study Team recently won the Chief Investigator/Study Team of the Year award, which was presented at the Annual Network Meeting on the 4th February 2015. The awards showcase and celebrate the impact that motivated individuals and teams have had on the set up and delivery of NIHR Portfolio research in the North East and North Cumbria. The DISCARD2 Trial was funded by the NIHR’ Research for Patient Benefit Programme and was a particular highlight for regional gastroenterology research.

The multi-centre study, sponsored by South Tyneside NHS Foundation Trust, recruited patients from six hospitals in the North East and North Cumbria (NENC) local research network (LCRN). In addition to South Tyneside, University Hospital of North Tees, Northumbria Healthcare NHS Foundation Trust, North Cumbria University Hospital NHS Foundation Trust, County Durham & Darlington NHS Foundation Trust, and South Tees Hospitals NHS Foundation Trust were involved. The trial involved around 40 endoscopists.

Working with Durham Clinical Trials Unit (DCTU), the study used the collaborative infrastructure created by the Northern Region Endoscopy Group (NREG) and the NENC Clinical Research Network (CRN), including the Gastroenterology Speciality Group (SG), to successfully deliver DISCARD2. Each of the recruiting centres demonstrated rapid approval times; network-funded nurses supported the study, enabling efficient recruitment to time and target. There were 1731 phase 1 patients and 730 phase 2 patients recruited over an 18 month period.

DISCARD2 assessed the accuracy of narrow band imaging (NBI) optical diagnosis in characterising colonic polyps found at colonoscopy during routine practice compared with standard histological assessment of small colonic polyps (<10mm).

The BSG congratulates Professor Rees and the whole DISCARD2 team on their award.

The 17th International Congress of Mucosal Immunology (ICMI 2015)

Wednesday, 04 February 2015 16:01

Scientists in Gastroenterology and BSG Research Committee are pleased to support a State of the Art session (Arthur Kaser as speaker) at the upcoming ICMI 2015 meeting in Berlin, Germany, July 14-18, 2015.

Page 1 of 2